- Q1 2024 Chimerix Inc Earnings Call TranscriptMay 01, 2024Earnings
- Q4 2023 Chimerix Inc Earnings Call TranscriptFeb 29, 2024€1.12 (-7.95%)Earnings
- Q3 2023 Chimerix Inc Earnings Call TranscriptNov 02, 2023€0.8992 (+2.51%)Earnings
- Q2 2023 Chimerix Inc Earnings Call TranscriptAug 03, 2023€1.04Earnings
- Chimerix Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Chimerix Inc Earnings Call TranscriptMay 04, 2023€1.02 (-0.44%)Earnings
- Q4 2022 Chimerix Inc Earnings Call TranscriptMar 02, 2023€1.55 (+6.01%)Earnings
- Chimerix Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Q3 2022 Chimerix Inc Earnings Call TranscriptNov 03, 2022€1.82 (-4.55%)Earnings
- Q2 2022 Chimerix Inc Earnings Call TranscriptAug 08, 2022€2.26 (-10.79%)Earnings
- Q1 2022 Chimerix Inc Earnings Call TranscriptMay 16, 2022€2.04 (-41.86%)Earnings
- Q4 2021 Chimerix Inc Earnings Call TranscriptMar 01, 2022€4.87 (-1.78%)Earnings
- Chimerix Inc to Discuss Positive ONC201 Data in Recurrent H3 K27M-mutant Diffuse Midline Glioma Call TranscriptNov 22, 2021
- Chimerix Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 08, 2021
- Q3 2021 Chimerix Inc Earnings Call TranscriptNov 04, 2021€5.21 (+4.73%)Earnings
- Q2 2021 Chimerix Inc Earnings Call TranscriptAug 05, 2021€5.57 (+4.90%)Earnings
- Chimerix Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- Q1 2021 Chimerix Inc Earnings Call TranscriptMay 06, 2021€6.6 (-11.06%)Earnings
- Q4 2020 Chimerix Inc Earnings Call TranscriptFeb 25, 2021€8.48 (+3.41%)Earnings
- Chimerix Inc to Acquire Oncoceutics Inc - Conference Call TranscriptJan 08, 2021
- Chimerix Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 12, 2020
- Q3 2020 Chimerix Inc Earnings Call TranscriptNov 05, 2020€2.5 (+0.81%)Earnings
- Q2 2020 Chimerix Inc Earnings Call TranscriptAug 10, 2020€2.68Earnings
- Chimerix Inc DSTAT Clinical Update Conference Call TranscriptApr 29, 2020
- Q4 2019 Chimerix Inc Earnings Call TranscriptFeb 25, 2020€1.71 (+11.76%)Earnings
- Chimerix Inc at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 13, 2019
- Q3 2019 Chimerix Inc Earnings Call and Operational Updates TranscriptNov 05, 2019€1.39 (-2.11%)Earnings
- Chimerix Inc CX-01 Call TranscriptJul 31, 2019
- Q1 2019 Chimerix Inc Earnings Call TranscriptMay 09, 2019€2.5 (+6.38%)Earnings
- Q4 2018 Chimerix Inc Earnings Call TranscriptMar 05, 2019€1.8 (-8.16%)Earnings
Chimerix Inc CX-01 Call Transcript
Good morning, and welcome to the Chimerix conference call. Please be advised that today's call is being recorded at the company's request. I would now like to turn the call over to Michelle LaSpaluto from Chimerix.
Thank you. Earlier today, we issued a press release announcing Chimerix's worldwide license of CX-01 from Cantex Pharmaceuticals. The press release is available on the company's website. You may also access today's call via webcast on the Investors section of the Chimerix website. An archive of the webcast will be available approximately 2 hours after the conclusion of the event.
With me on today's call are Mike Sherman, President and Chief Executive Officer; Mike Andriole, Chief Financial and Chief Business Officer; Garrett Nichols, Chief Medical Officer; Roy Ware, Chief Manufacturing and Technology Officer; and Randall Lanier, Chief Science Officer, will be available for questions following our formal remarks.
Before we begin, I'd
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)